Loading clinical trials...
Loading clinical trials...
Ultrasound-guided Quadratus Lumborum Block for Postoperative Pain Control After Endoscopic Prostatectomy - Double Blinded, Placebo-controlled, Randomised Trial.
Laparoscopic prostatectomy (LP) is characterized by substantial tissue trauma, despite its minimally -invasive approach. Although postoperative pain intensity is lower when compared to open procedures, the use of opioids is common. Retrospective review of available LP cases revealed that although analgesic demand varied, nearly all of our LP patients required opioids postoperatively. Bilateral Quadratus Lumborum Block (QLB), being one of relatively new features of regional anesthesia, offers good analgesia of abdominal wall, with the potential for control of visceral pain. This study was established to evaluate its effectiveness in alleviating pain after radical prostatectomy in a double - blind, placebo - controlled manner.
Age
40 - 80 years
Sex
MALE
Healthy Volunteers
No
Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care
Warsaw, Poland
Start Date
July 25, 2018
Primary Completion Date
October 21, 2019
Completion Date
October 21, 2019
Last Updated
October 22, 2019
50
ACTUAL participants
Qadratus Lumborum Block
PROCEDURE
30 milliliters of 0.375% Ropivacaine
DRUG
30 milliliters of 0.9% NaCl
DRUG
Lead Sponsor
Centre of Postgraduate Medical Education
NCT06842498
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05691465